You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Inhibitory activities of amphotericin B, fluconazole, and voriconazole against clinical isolates of Cryptococcus neoformans (n = 46) from initial cerebro-spinal fluid culture

From: Correlation of anti-fungal susceptibility with clinical outcomes in patients with cryptococcal meningitis

Anti-fungal agent Cumulative % inhibited at MIC (μg/ml)
0.06 0.12 0.25 0.5 1 2 4 8 16 32
Amphotericin B 0 0 6.5 36.9 82.6 100     
Fluconazole    0 0 0 8.7 28.3 74 95.7 100
Voriconazole 8.7 52.2 91.3 100